Bacterial detection and use of antibiotics
DOI:
https://doi.org/10.16921/pfr.v9i2.319Keywords:
antibiotics, update, microbiologyAbstract
The latest CLSI report raises several new developments that have a strong impact on microbiology laboratory technology and the rational use of antibiotics. Highlights of the report are summarized below.
Downloads
Download data is not yet available.
References
1. Satlin MJ, Lewis JS, Weinstein MP, et al. Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints. Clin Infect Dis. 2020;71(9):e523-e529. doi:10.1093/cid/ciaa121
2. Prava Rout B, Behera B, Kumar Sahu K, Praharaj I, Otta S. An overview of colistin resistance: A breach in last line defense. Med J Armed Forces India. 2023;79(5):516-525. doi:10.1016/j.mjafi.2023.06.006
3. Satlin MJ, Lewis JS, Weinstein MP, et al. Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints. Clin Infect Dis. 2020;71(9):e523-e529. doi:10.1093/cid/ciaa121
4. Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos Instituto Nacional de Enfermedades Infecciosas. ANLIS “Dr. C. G. Malbrán” http://antimicrobianos.com.ar/category/novedad_clsi/
5. American College of Obstetricians and Gynecologists. Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee Opinion, Number 797, Obstet Gynecol. 2020;135(2):e51-e72.
6. Merino-Bohorquezuez V y cols. (10.1016/j.cmi.2018.02.005),
2. Prava Rout B, Behera B, Kumar Sahu K, Praharaj I, Otta S. An overview of colistin resistance: A breach in last line defense. Med J Armed Forces India. 2023;79(5):516-525. doi:10.1016/j.mjafi.2023.06.006
3. Satlin MJ, Lewis JS, Weinstein MP, et al. Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints. Clin Infect Dis. 2020;71(9):e523-e529. doi:10.1093/cid/ciaa121
4. Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos Instituto Nacional de Enfermedades Infecciosas. ANLIS “Dr. C. G. Malbrán” http://antimicrobianos.com.ar/category/novedad_clsi/
5. American College of Obstetricians and Gynecologists. Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee Opinion, Number 797, Obstet Gynecol. 2020;135(2):e51-e72.
6. Merino-Bohorquezuez V y cols. (10.1016/j.cmi.2018.02.005),
Downloads
Published
2024-08-08
How to Cite
1.
Herrera D, Troya Altamirano C. Bacterial detection and use of antibiotics. PFR [Internet]. 2024Aug.8 [cited 2025Oct.15];9(2). Available from: https://practicafamiliarrural.org/index.php/pfr/article/view/319
Issue
Section
Miscellaneous articles
